Detalhe da pesquisa
1.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
2.
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations.
Hered Cancer Clin Pract
; 22(1): 7, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741145
3.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
4.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
5.
Choices for cancer prevention for women with a BRCA1 mutation? a personal view.
Hered Cancer Clin Pract
; 21(1): 26, 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031144
6.
Genetic testing for hereditary breast cancer in Poland: 1998-2022.
Hered Cancer Clin Pract
; 21(1): 9, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312208
7.
Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762691
8.
Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer.
Br J Cancer
; 127(5): 879-885, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710751
9.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Br J Cancer
; 127(1): 84-91, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256754
10.
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.
Breast Cancer Res Treat
; 191(3): 631-641, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846626
11.
Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer.
Ann Surg Oncol
; 29(13): 8072-8082, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074200
12.
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT.
Clin Genet
; 101(3): 317-323, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897671
13.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
14.
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.
Hered Cancer Clin Pract
; 20(1): 13, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395863
15.
An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
Cancer
; 127(17): 3183-3193, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077552
16.
The risk of contralateral breast cancer: a SEER-based analysis.
Br J Cancer
; 125(4): 601-610, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34040177
17.
PALB2 mutations and prostate cancer risk and survival.
Br J Cancer
; 125(4): 569-575, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006922
18.
Survival from breast cancer in women with a BRCA2 mutation by treatment.
Br J Cancer
; 124(9): 1524-1532, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597716
19.
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer.
Breast Cancer Res Treat
; 186(1): 177-189, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33174180
20.
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 187(2): 515-523, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423179